Menu
Not yet recruiting NCT06807333

Transforming Diabetes Care: Pharmacist-Led Education and Its Impact on Patient Knowledge, Self-Management, and Health Outcomes

No phase Interventional Diabetes Mellitus

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Pharmacist led Education.
Who it may be relevant to
Registry conditions: Diabetes Mellitus. Basic parameters: 18 years — 60 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Pakistan
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

This interventional study is to evaluate the impact of pharmacist-led education on diabetic patients' knowledge, self-management, and overall health outcomes. Participants in this study will attend pharmacist-led educational sessions designed to improve their understanding of diabetes and self-care practices. Researchers will assess changes in patients' knowledge, self-management behaviors, and clinical health markers before and after the intervention. The study will compare pre- and post-intervention results to determine the effectiveness of pharmacist-led education in transforming diabetes care.

Detailed description

The purpose of this study is to investigate whether pharmacist-led education can enhance the knowledge, self-management behaviors, and health outcomes of diabetic patients. Effective diabetes management requires a comprehensive understanding of the disease, adherence to lifestyle modifications, and consistent monitoring of health indicators. Poor knowledge and suboptimal self-care can lead to inadequate glycemic control, complications, and reduced quality of life. This study will evaluate the impact of pharmacist-led educational interventions on patients' motivation, diabetes-related knowledge, and self-care behaviors, as well as their effects on clinical outcomes, including improved HbA1c levels, reduced hypo- and hyperglycemic episodes, and enhanced patient satisfaction. By addressing these critical aspects, the study aims to highlight the transformative role of pharmacist-led education in advancing diabetes care and fostering sustainable, patient-centered healthcare practices.

Interventions

  • Behavioral Pharmacist led Education
    Pharmacist-led education for diabetic patients focuses on enhancing their understanding of the disease, improving self-management skills, and promoting better health outcomes. The education covers key aspects of diabetes, such as the importance of blood sugar control, the role of diet and exercise, and how to monitor blood glucose levels. Patients are also taught effective self-management strategies, including how to make healthy food choices, incorporate physical activity into daily routines, a

Primary outcome measures

  • Diabetes Knowledge Score(DKQ-24) [Time frame: 3 months]
  • Diabetes Management Self-Efficacy Score (DMSQ-16) [Time frame: 3 months]
  • HbA1C Levels (%) [Time frame: 3 months]

Eligibility criteria

Inclusion criteria

  • We will include all confirmed diabetic patients who visit the SIH endocrinology OPD Clinic during the study duration.
  • Both male and female patients visiting the Endocrinology Unit of the hospital will be eligible.
  • Patients with HbA1c levels greater than 8% will be included.
  • Both follow-up and newly diagnosed patients will be considered.
  • Patients who sign the informed consent form will be enrolled in the study.

Exclusion criteria

  • We will exclude patients with gestational diabetes mellitus (GDM).
  • Patients with central obesity will not be included in the study.
  • Type 1 diabetes mellitus (DM) patients under the age of 20 will be excluded.
  • Patients with inadequate medical history will be excluded from participation.
  • Patients with HbA1c levels less than 8% will not be included.
  • Patients who do not provide informed consent or express a lack of interest in the study will be excluded.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
N/A
Model
Single group
Masking
Open label
Primary purpose
Supportive care

Study locations

Pakistan · 1 center
  • Shifa International Hospital — Islamabad

Identifiers

NCT: NCT06807333 · 318-24

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗